The emerging role of cholesterol metabolism in gynecologic cancer development and therapy.
The significance of cholesterol metabolism in cancer is a topic of renewed interest.
APA
Liu H, Zhou Y, et al. (2026). The emerging role of cholesterol metabolism in gynecologic cancer development and therapy.. Apoptosis : an international journal on programmed cell death, 31(1), 7. https://doi.org/10.1007/s10495-025-02200-2
MLA
Liu H, et al.. "The emerging role of cholesterol metabolism in gynecologic cancer development and therapy.." Apoptosis : an international journal on programmed cell death, vol. 31, no. 1, 2026, pp. 7.
PMID
41518525
Abstract
The significance of cholesterol metabolism in cancer is a topic of renewed interest. Cholesterol is an essential factor for mammal cells, for it is not only involved in constituting the cell membrane, but also serves as a precursor to steroid hormones and bile acids. Numerous studies have provided increasing evidence of its high relevance to cancer progression. Targeting cholesterol metabolism by using cholesterol metabolism inhibitors has offered another therapeutic strategy for reversing drug resistance in tumors. Here, the regulatory process of cholesterol homeostasis under normal physiological conditions was introduced. Then, the mechanism by which cholesterol metabolism disorder caused gynecologic cancer development and therapy resistance was summarized. Finally, the therapeutic strategies targeting cholesterol metabolism were also discussed in this review.
MeSH Terms
Humans; Cholesterol; Female; Genital Neoplasms, Female; Animals; Drug Resistance, Neoplasm; Homeostasis; Lipid Metabolism
같은 제1저자의 인용 많은 논문 (5)
- From feasibility to translational pathways: a bibliometric and knowledge-mapping analysis of urine-based liquid biopsy in urologic cancers (2015-2025).
- The Current Status of Radionuclide Tumor Targeting Diagnosis and Therapy Based on FAP-2286: From Preclinical Studies to Clinical Application.
- Cleavage-Resistant CYLD Protects Against Autoimmune Hepatitis.
- Single-Cell Computational Frameworks for Quantifying BET Bromodomain Inhibitor Resistance and Screening Re-Sensitizer Drugs in Triple-Negative Breast Cancer.
- Target-Centric Multiplexed Screening of an Herbal Extract Identifies a Novel Dual A/A Receptor Antagonist for Cancer Immunotherapy.